
Healthy Investments Ltd Approves FY 2025-26 Results, Director Appointment, and Promoter Reclassification
Healthy Investments Ltd announced on May 22, 2026, that its Board of Directors convened a meeting approving the audited financial results for the fourth quarter and financial year ending March 31, 2026, along with the audited financial statements for the 2025-26 financial year.During the meeting, the Board also approved the reclassification of outgoing promoters from the 'Promoter Group' to the 'Public' category. Furthermore, the company approved the appointment of Mr. Manish Kumar Shukla (DIN: 08520576) as an Additional Director, categorized as a Non-Executive Independent Director.
The company's financial performance data for the period ended March 31, 2026, shows the following key outcomes:
Quarterly and Annual Financial Results (in ₹ Millions)
The reported revenues for the quarter ended March 31, 2026, totaled 0.973. This compared to 0.913 in the preceding three months ended December 31, 2025, and 0.044 in the corresponding three months ended March 31, 2025.Year-to-date revenue for the period ended March 31, 2026, was 2.440, following a year-to-date figure of 2.042 for the previous period ended December 31, 2024, and 2.086 for the full year ended March 31, 2025.
Key expenses included a total recorded expense of 0.409 for the quarter ended March 31, 2026.
| Financial Metric | Qtr ended 31.03.2026 (Audited) | Pre-Qtr ended 31.12.2025 (Unaudited) | Cor. Qtr ended 31.03.2025 (Audited) | Year ended 31.03.2026 (Audited) | Year to date (31.12.2024) (Unaudited) | Year ended 31.03.2025 (Audited) |
|---|---|---|---|---|---|---|
| Total Revenue (₹ in Millions) | 0.973 | 0.913 | 0.044 | 2.440 | 2.042 | 2.086 |
| Total Expenses (₹ in Millions) | 0.409 | 0.359 | 0.340 | 1.781 | 0.996 | 1.336 |
| Profit Before Tax (₹ in Millions) | 0.564 | 0.554 | (0.296) | 0.659 | 1.046 | 0.750 |
| Net Profit/(Loss) for the Period (₹ in Millions) | 0.443 | (0.391) | 3.178 | 0.539 | (9.054) | (5.877) |
Financial Position Summary (as of March 31, 2026)
The Balance Sheet summary reveals the company’s total assets stood at 254.144 ₹ Million as of March 31, 2026, compared to 218.628 ₹ Million on the same date in the previous year.Total equity increased to 243.009 ₹ Million, driven by Other Equity which stood at 240.559 ₹ Million.
| Balance Sheet Component | As at 31-03-2026 (₹ in Millions) | As at 31-03-2025 (₹ in Millions) |
|---|---|---|
| ASSETS | ||
| Total Assets | 254.144 | 218.628 |
| EQUITY & LIABILITIES | ||
| Other Equity | 240.559 | 209.862 |
| Total Equity and Liabilities | 254.144 | 218.628 |
Cash Flow Highlights
The Cash Flow Statement for the year ended March 31, 2026, showed Net Cash from Operating Activities (A) at (1.835) ₹ Million, up from (1.399) ₹ Million in the previous fiscal year.For the year ended March 31, 2026, the net cash from investing activities (B) totaled 1.831 ₹ Million, compared to 1.753 ₹ Million for the previous year.
| Metric | 31-03-2026 (₹ in Millions) | 31-03-2025 (₹ in Millions) |
|---|---|---|
| Profit / (Loss) before tax | 0.659 | 0.750 |
| Operating Profit before Working Capital Changes | (1.781) | (1.336) |
| Net Cash from Operating Activities (A) | (1.835) | (1.746) |
| Net Cash from Investing Activities (B) | 1.831 | 1.753 |
| Net Increase / (Decrease) in Cash and Cash Equivalents (D=A+B+C) | (0.004) | 0.007 |
| Cash and Cash Equivalents at End of Period (F) | 0.040 | 0.046 |
Audit Opinion
The company's statutory auditors issued an Audit Report providing an Unmodified Opinion on the Financial Results for the quarter ended March 31, 2026, and the year-to-date results for the period from April 01, 2025 to March 31, 2026. This confirms that the financial results give a true and fair view in conformity with applicable accounting standards.Stock Price Movement
Heading into 14:15, Healthy Investments Ltd shares are holding steady at ₹3.20, seeing zero percentage movement today. The stock has been locked at this exact price point, as the intraday high and low are identically marked at ₹3.20.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.